Patents Assigned to BRAINGUARD CO.,LTD.
  • Patent number: 10010574
    Abstract: A silk peptide having neuroprotective and neurofunctional activities and its preparation method are discussed. One method relates to preparing silk protein preferably having neuroprotective activity with weight average molecular weight of 200-100,000 by hydrolysis of silk fibroin; also discussed are a composition for preventing or treating brain disease comprising silk peptide and pharmaceutically acceptable carrier, and a composition for improving brain function.
    Type: Grant
    Filed: July 31, 2004
    Date of Patent: July 3, 2018
    Assignee: BRAINGUARD CO., LTD.
    Inventors: Sung Su Kim, Cheol Hyoung Park, Sang-Hyung Lee, Wan-Seok Joo, Won Bok Lee
  • Publication number: 20130195937
    Abstract: A method for preventing or treating a brain nervous disease includes administering to a subject in need thereof a therapeutically effective amount of a carbon nanotube, wherein the nervous disease is a brain disease or a traumatic central nervous system injury. The composition of the present invention enables patients to recover from physical damage to the brain, exhibits superior efficacy for inhibiting the onset of Parkinson's disease and strokes in animal models for Parkinson's disease and strokes, and the cytotoxic effects of beta amyloid in beta amyloid toxicity tests. Therefore, the composition of the present invention can be effectively used in the preparation of medicine for protecting cranial nerves, therapeutic agents for preventing or treating brain disease, or therapeutic agents for treating traumatic injuries to the central nervous system.
    Type: Application
    Filed: July 14, 2011
    Publication date: August 1, 2013
    Applicant: BRAINGUARD CO., LTD.
    Inventors: Yoonhwa Jeong, Hyun Jung Lee, Do Yeon Lee, Yoo Hun Noh, Do Hee Kim, Ok Hyeon Kim, Ji Ae Park, Jiwon Lee
  • Publication number: 20110105402
    Abstract: A silk peptide having neuroprotective and neurofunctional activities and its preparation method are discussed. One method relates to preparing silk protein preferably having neuroprotective activity with weight average molecular weight of 200-100,000 by hydrolysis of silk fibroin; also discussed are a composition for preventing or treating brain disease comprising silk peptide and pharmaceutically acceptable carrier, and a composition for improving brain function.
    Type: Application
    Filed: July 31, 2004
    Publication date: May 5, 2011
    Applicant: BRAINGUARD CO., LTD.
    Inventors: Sung Su Kim, Yong Koo Kang, Cheol Hyoung Park, Sang-Hyung Lee, Wan-Seok Joo, Won Bok Lee, Hee Sun Chae, Hye Kyung Na
  • Publication number: 20100093641
    Abstract: The present invention relates to a silk protein-mimicking peptide represented by the following Formula 1, a composition for preventing or treating a brain disease, a composition for improving a brain or cognitive function and a composition for preventing or treating diseases, disorders or conditions associated with oxidative stress comprising the peptide: Gly-Xaa1-Gly-Xaa2 ??(1) wherein Xaa1 is Ala, Val, Ser, Tyr, Asp, Glu, Thr, Met, Ile, Leu, Phe, His, Lys or Arg; Xaa2 is Ala, Tyr, Val, Ser, Asp, Glu, Thr, Met, Ile, Leu, Phe, His, Lys or Arg; or Xaa2 represents Ala, Tyr, Val, Ser, Asp, Glu, Thr, Met, Ile, Leu, Phe, His, Lys or Arg residue linked to Gly-Xaa3; and Xaa3 is Tyr, Val, Ala, Ser, Asp, Glu, Thr, Met, Ile, Leu, Phe, His, Lys or Arg.
    Type: Application
    Filed: October 17, 2007
    Publication date: April 15, 2010
    Applicant: BRAINGUARD CO.,LTD.
    Inventors: Sung Su Kim, Do Yeon Lee, Yoo Hun Noh
  • Publication number: 20090148417
    Abstract: The present invention relates to a scaffold for transplanting a stem cell comprising a carbon nanotube without cytotoxicity, and a composition for stem cell therapy comprising (a) a stem cell; and (b) a carbon nanotube serving as a stem cell scaffold without cytotoxicity. The scaffold for transplanting stem cells comprising carbon nanotubes show excellent effects without cytotoxicity on networking between differentiated stem cells and tissues present in transplantation sites, thereby showing significant cell therapy efficacy.
    Type: Application
    Filed: July 27, 2006
    Publication date: June 11, 2009
    Applicant: BRAINGUARD CO., LTD
    Inventors: Sung Su Kim, Yoo Hun Noh, Ok Ja Yoon, Seung Hoon Yoo